Emrullah Yilmaz

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Şevin Turcan, Daniel Rohle, Anuj Goenka et al. · Nature · 2012 · 2K citations · Full text

Medicine, Cancer Biology, Oncology +14

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

Selvaraju Veeriah, Barry S. Taylor, Shasha Meng et al. · Nature Genetics · 2009 · 398 citations · Full text

Medicine, Neuroscience, Oncology +17

MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors

Adrian J. Luna, Rosa T. Sterk, Anastacia M. Griego-Fisher et al. · PLoS Pathogens · 2021 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

Association of Treatment Strategies and Tumor Characteristics With Overall Survival Among Patients With Anaplastic Thyroid Cancer

Shannon S. Wu, Eric Lamarre, Anirudh Yalamanchali et al. · JAMA Otolaryngology–Head & Neck Surgery · 2023 · 32 citations · Full text

Medicine, Immunology, Oncology +11